0001157523-22-000122.txt : 20220131 0001157523-22-000122.hdr.sgml : 20220131 20220131162051 ACCESSION NUMBER: 0001157523-22-000122 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20220131 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220131 DATE AS OF CHANGE: 20220131 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CROSS COUNTRY HEALTHCARE INC CENTRAL INDEX KEY: 0001141103 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HELP SUPPLY SERVICES [7363] IRS NUMBER: 134066229 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-33169 FILM NUMBER: 22574278 BUSINESS ADDRESS: STREET 1: 6551 PARK OF COMMERCE BOULEVARD, N.W. CITY: BOCA RATON STATE: FL ZIP: 33487 BUSINESS PHONE: 8003472264 MAIL ADDRESS: STREET 1: 6551 PARK OF COMMERCE BOULEVARD, N.W. CITY: BOCA RATON STATE: FL ZIP: 33487 FORMER COMPANY: FORMER CONFORMED NAME: CROSS COUNTRY INC DATE OF NAME CHANGE: 20010521 8-K 1 a52571116.htm CROSS COUNTRY HEALTHCARE, INC. 8-K

UNITED STATES 
 SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 
 
 
FORM 8-K
 
 
 
CURRENT REPORT


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported) January 31, 2022
 graphic
 
 
 
Cross Country Healthcare, Inc.
(Exact name of registrant as specified in its charter)
 
 

Delaware
0-33169
13-4066229
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
 
6551 Park of Commerce Boulevard, N.W., Boca Raton, Florida 33487
(Address of Principal Executive Office) (Zip Code)

(561) 998-2232
(Registrant’s telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report)
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class Trading Symbol Name of each exchange on which registered
Common stock, par value $0.0001 per share
 CCRN
 The Nasdaq Stock Market LLC

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2).
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01          Regulation FD Disclosure.

On January 31, 2022, the Company issued a press release, a copy of which is furnished herewith as Exhibit 99.1. Pursuant to General Instruction B.2 of Current Report on Form 8-K, the information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of such section. Furthermore, the information in this Item 7.01, including Exhibit 99.1, shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of the general incorporation language of such filing, except as shall be expressly set forth by specific reference in such filing.

Item 9.01          Financial Statements and Exhibits
 
(d) Exhibits

          
Exhibit
     
Description
 
 
 
 
 
 
       
  104.1  
Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
 

 
 
CROSS COUNTRY HEALTHCARE, INC.
 
 
 
 
 
 
 
 
Dated:
January 31, 2022
By:
/s/ William J. Burns
  
 
 
 
Name:  William J. Burns
 
 
 
Title: Executive Vice President & Chief Financial Officer



EX-99.1 2 a52571116ex99_1.htm EXHIBIT 99.1
Exhibit 99.1

Cross Country Healthcare Announces Fourth Quarter and Full Year 2021 Earnings Release Date and Conference Call Information

BOCA RATON, Fla.--(BUSINESS WIRE)--January 31, 2022--Cross Country Healthcare, Inc. (Nasdaq: CCRN) will hold its quarterly conference call to discuss its fourth quarter and full year 2021 financial results on Wednesday, February 23, 2022 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the “Company”) intends to distribute its earnings press release after market close on Wednesday, February 23, 2022.

This call will be webcast live and can be accessed at the Company’s website at ir.crosscountryhealthcare.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from February 23rd through March 9th at the Company’s website and a replay of the conference call will be available by telephone by calling 800-391-9853 from anywhere in the U.S. or 203-369-3269 from non-U.S. locations – Passcode: 2022.

About Cross Country Healthcare

Cross Country Healthcare, Inc. (CCH) is a leader in providing total talent management including strategic workforce solutions, contingent staffing, permanent placement, and consultative services for healthcare customers. Leveraging our 35 years of industry expertise and insight, CCH solves complex labor-related challenges for customers while providing high-quality outcomes and exceptional patient care. As a multi-year Best of Staffing® Award winner, CCH is committed to an exceptionally high level of service to both our clients and our healthcare professionals. CCH was the first publicly traded staffing firm to obtain The Joint Commission Certification, which it still holds with a Letter of Distinction. In 2021, CCH was listed as one of the top four staffing and recruiting employers for women by InHerSights and earned Energage’s inaugural 2021 Top Workplaces USA award. CCH has a longstanding history of investing in its diversity, equality, and inclusion strategic initiatives as a key component of the organization’s overall corporate social responsibility program which is closely aligned with its core values to create a better future for its people, communities, the planet, and its shareholders.

Copies of this and other news releases as well as additional information about Cross Country Healthcare can be obtained online at ir.crosscountryhealthcare.com. Shareholders and prospective investors can also register to automatically receive the Company's press releases, filings with the Securities and Exchange Commission, and other notices by e-mail.

Contacts

Cross Country Healthcare, Inc.
William J. Burns, 561-237-2555
Executive Vice President & Chief Financial Officer
wburns@crosscountry.com

EX-101.SCH 3 ccrn-20220131.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 ccrn-20220131_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name EX-101.PRE 5 ccrn-20220131_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 cc_logo.jpg begin 644 cc_logo.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.0.1
Document and Entity Information
Jan. 31, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 31, 2022
Entity Registrant Name Cross Country Healthcare, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 0-33169
Entity Tax Identification Number 13-4066229
Entity Address, Address Line One 6551 Park of Commerce Boulevard
Entity Address, Address Line Two N.W.
Entity Address, City or Town Boca Raton
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33487
City Area Code 561
Local Phone Number 998-2232
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0001141103
Title of 12(b) Security Common stock, par value $0.0001 per share
Trading Symbol CCRN
Security Exchange Name NASDAQ
XML 8 a52571116_htm.xml IDEA: XBRL DOCUMENT 0001141103 2022-01-31 2022-01-31 false 0001141103 8-K 2022-01-31 Cross Country Healthcare, Inc. DE 0-33169 13-4066229 6551 Park of Commerce Boulevard N.W. Boca Raton FL 33487 561 998-2232 Common stock, par value $0.0001 per share CCRN NASDAQ false false false false false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( )F"/U0'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " "9@C]4#R-;;>X K @ $0 &1O8U!R;W!S+V-O&ULS9+/ M2L0P$(=?17)OITG50^CFHGA2$%Q0O(5D=C?8_"$9:??M;>MN%]$'\)B97[[Y M!J8S29J8\3G'A)DJLD2:CIIA/>&M6?/K,_0*S!K!'CX$*\)H#4_/$ M=!S[#BZ &4:8??DNH%V)2_5/[-(!=DJ.Q:VI81CJH5URTPX7Y9U*Q<* MZ6!P^E6_[D)] 5!+ P04 " "9@C]4F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M )F"/U1R:=!U6@0 /T0 8 >&PO=V]R:W-H965T&UL MG9A=<^(V%(:OM[]"P_2BG4FP)3Y"=@@SA"2[Z6:S--!FIIU>"%M@36S+E>00 M_GV/#-AL:HYI;\ R/J\?Z4COD1BNE7XQD1"6O"5Q:JY:D;791\\S0202;MHJ M$RG\LE0ZX1::>N693 L>%D%)[#'?[WL)EVEK-"SN3?5HJ'(;RU1,-3%YDG"] MN1:Q6E^U:&M_XTFN(NMN>*-AQE=B)NQOV51#RRM50IF(U$B5$BV65ZTQ_7C- M>BZ@>.)W*=;FX)JXKBR4>G&-^_"JY3LB$8O .@D.7Z]B(N+8*0''WSO15OE. M%WAXO5>_*SH/G5EP(R8J?I:AC:Y:@Q8)Q9+GL7U2Z\]BUZ$",%"Q*3[)>OML MM]LB06ZL2G;!0)#(=/O-WW8#<1C C@2P70 KN+5F=7PJX0X.[I100Z#; E/0W*;6FDWY#[=9AM&;>A9>(E[U MV M@M=;079$\!>>MDF'GA'F,_9]N =L)2 K 5FAUSFB-U&O0I,_QPMC-:3P+T2R M4TIV"LEN4Y_GFTS4]1 /'YQ_02"Z)40751D#05A0W,5\54>!QR]Y; 3"T2LY M>J<-QE1HJ=P<" G,I-IQP97VF?_APX>&W/=+MCZJN)N/3V(E7?8!\I$GM62X MSD0K8\A$Y:G5&_)9\-A& =?B#*9ZT$9 +TK0BU- 04WI3.EBZ9R1F85Q)$J7 M;YZHL)8>%[^Y10@')>'@%,([&0ORF"<+H>M < W_O-.A_4N$YK*DN3R%9L[? MR'T(DT\N95 ,&L*&*]+.>=?O]QG#\*A?N:)_"N X#+4PYFQ_01[@.?(MKG:2T]]" M%5FY?'X"!1NYR9;Q=%.+A@LVHAULV$\R^@D,FX8U>0\C]D:^B'HH7,KW?4J[ ME/H=C*PR>88;\EQ:V/Y ^:7LI\7/9":"'!9I/1BNY!8U[%;@>!:\G)&,:_+* MXUR0'_VV8R893!(3P183XZXJ ,/]>JYYZ)(\VR0+5;MD&P0FDZ='C*3R>X;; M]7[(R.U;$/%T)8[NR!N$'L>SF_&O=4S>P6'6_3'PE;L9;D@LEJ#DMR] 6&_/ MVMN&55EQOETH"Z?EXC(2'):I>P!^7RIE]PUW9"[_\1C] U!+ P04 " "9 M@C]4GZ ;\+$" #B# #0 'AL+W-T>6QEO%DN7/ZZZ>S;"=I=67=A['-HN6/O.-%Q[I#)6,>=56R=M8SDK6W!2 M,EG>W&2)8D+38JT[=:=<2PZFTVY#;VA2K"NCSY:4!H-?RA0GCTQNZ)9)L;=B M6,N4D*=@7H+A8*2QQ'DJ?$,78&F? KP(&K XU7=>&18/QA<0&>7=J?$,:\M.B^4M/3L,/S[)WMB2VSG- M@DZF8BUY!72LJ(_PZTR3 .B<45XH!:N-9@.'R6,4?-@#E_(!6OBMNHK=5R3T MXE,);2"PU4GTA$8QA D*Q+^,%F)?A+W]K;"D$8_&?>S\;O2@?^^,X_>65Z(? M]+Z:\V/1%WATUC3R]$&*6BL>]O[+"8LUF_S(T5CQY+/!I!R\@5M*'KEUXG!I M^6%9L^.]FZ:IKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE< MA!OZ%>Y7>>9 ]IV03NA1.XJRY/K%.?7A'=O["_PJOE]?\HIUTNUF<$//\A=> MBD[E\ZI[J,NXZBQ_AOMHD\%G'!QR>(W?#$T

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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.0.1 html 1 118 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://crosscountryhealthcare.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports a52571116.htm a52571116ex99_1.htm ccrn-20220131.xsd ccrn-20220131_lab.xml ccrn-20220131_pre.xml cc_logo.jpg http://xbrl.sec.gov/dei/2021 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "a52571116.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "a52571116.htm" ] }, "labelLink": { "local": [ "ccrn-20220131_lab.xml" ] }, "presentationLink": { "local": [ "ccrn-20220131_pre.xml" ] }, "schema": { "local": [ "ccrn-20220131.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 29, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 118, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ccrn", "nsuri": "http://crosscountryhealthcare.com/20220131", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "a52571116.htm", "contextRef": "c20220131to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "role": "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "a52571116.htm", "contextRef": "c20220131to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://crosscountryhealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001157523-22-000122-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001157523-22-000122-xbrl.zip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end